Not every reversible airflow limitation is asthma.
Zhao K, Nie H.
Chin Med J Pulm Crit Care Med. 2023 May 2;1(2):125-127. doi: 10.1016/j.pccm.2023.04.002. eCollection 2023 Jun.
Early-life risk factors for reversible and irreversible airflow limitation in young adults: findings from the BAMSE birth cohort.
Wang G, Kull I, Bergström A, Hallberg J, Bergström PU, Guerra S, Pershagen G, Gruzieva O, van Hage M, Georgelis A, Janson C, Lindén A, Melén E.
Thorax. 2021 May;76(5):503-507. doi: 10.1136/thoraxjnl-2020-215884. Epub 2020 Nov 12.
Airflow limitation--reversible or irreversible.
[No authors listed]
Lancet. 1988 Jan 2-9;1(8575-6):26-7.
Irritant-Induced Asthma.
Lemiere C, Lavoie G, Doyen V, Vandenplas O.
J Allergy Clin Immunol Pract. 2022 Nov;10(11):2799-2806. doi: 10.1016/j.jaip.2022.06.045. Epub 2022 Jul 9.
Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review.
Riley CM, Sciurba FC.
JAMA. 2019 Feb 26;321(8):786-797. doi: 10.1001/jama.2019.0131.
Copd.
McIvor RA, Tunks M, Todd DC.
BMJ Clin Evid. 2011 Jun 6;2011:1502.
Immunometabolism in the pathogenesis of asthma.
Qin Z, Chen Y, Wang Y, Xu Y, Liu T, Mu Q, Huang C.
Immunology. 2024 Jan;171(1):1-17. doi: 10.1111/imm.13688. Epub 2023 Aug 31.
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ.
N Engl J Med. 2004 Mar 4;350(10):1005-12. doi: 10.1056/NEJMoa021322.
Reslizumab (Cinqair) [Internet].
[No authors listed]
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.
Copd.
Kerstjens HA, Postma DS, Ten Hacken N.
BMJ Clin Evid. 2008 Dec 15;2008:1502.
